Position in DXCM
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$7,004
-$36,799 QoQ
Shares Held
104
-70.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#850
of 966 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Washington Trust Advisors, Inc. holds $20,460,836 across 11 Medical Devices names. DXCM ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
129,607 | $11,724,248 | |
| 2 | GMED |
Globus Medical Inc
|
45,006 | $3,555,924 | |
| 3 | PEN |
Penumbra Inc
|
7,671 | $2,422,118 | |
| 4 | ABT |
Abbott Laboratories
|
26,397 | $2,395,263 | |
| 5 | SYK |
Stryker Corp
|
562 | $176,939 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
967 | $61,897 | |
| 7 | BSX |
Boston Scientific Corp
|
1,410 | $60,178 | |
| 8 | MDT |
Medtronic plc
|
559 | $43,729 |
All Filings in DXCM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,004 | 104 | Shares | Other | 2026-07-29 | |
| 2023-12-31 | $43,803 | 353 | Shares | Other | 2024-01-18 | |
| 2023-09-30 | $14,928 | 160 | Shares | Other | 2023-10-18 | |
| 2023-03-31 | $23,700 | 204 | Shares | Other | 2023-05-11 | |
| 2022-12-31 | $25,818 | 228 | Shares | Other | 2023-02-08 | |
| 2022-09-30 | $18,363 | 228 | Shares | Other | 2022-10-14 | |
| 2022-06-30 | $16,992 | 228 | Shares | Other | 2022-07-25 | |
| 2022-03-31 | $23,022 | 45 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $93,429 | 174 | Shares | Other | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||